Entero Healthcare Solutions
- Market cap
- ₹ 6,402 Cr.
- P/E
- 53.9x
- P/B
- 3.86x
- 52-week range
- 944 – 1,920
- ROE
- 7%
- ROCE
- 10%
- Dividend yield
- 0%
- Debt / equity
- 0.4
- Sector
- Retailing
- Industry
- Pharmacy Retail
- Listed on
- NSE, BSE
About
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.
Quick check
The five things to look at first. Open one for more.
Latest announcements
Exchange filings and their impact on the company.
- Allotted 43,155 ESOP shares for ~Rs4.2 cr; ~0.1% dilution with negligible business impact.
Entero Healthcare allotted 43,155 equity shares of Rs 10 each on October 12, 2026 on exercise of vested options under Entero Employee Stock Option Plan 2023. 19,155 shares were issued at Rs 804 and 24,000 shares at Rs 1,124, taking total issued shares to 4,35,66,227 and raising about Rs 4.24 crore. The ~0.1% dilution has no meaningful impact on earnings or balance sheet.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Adequate safety
Rated A- by India Ratings- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| India Ratings | IND A- | Stable | 3 Dec 2025 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 3 Dec 2025 | Reaffirmed | IND A- | — | India Ratings | — |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 4 Nov 2026Upcoming | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2026 and other business matters |
| 7 Aug 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 25 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters |
| 12 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 12 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 8 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended June 30, 2025 |
| 27 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 996 | 993 | 1,034 | 1,097 | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,940 |
| Expenses | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,639 | 1,824 | 1,844 |
| Operating Profit | 29 | 29 | 29 | 30 | 42 | 50 | 49 | 50 | 62 | 68 | 86 | 97 |
| OPM % | 2.9% | 2.9% | 2.8% | 2.8% | 3.3% | 3.7% | 3.6% | 3.6% | 4% | 4% | 4.5% | 5% |
| Other Income | 2 | 2 | 9 | 13 | 11 | 8 | 7 | 6 | 5 | −4 | 4 | 3 |
| Interest | 18 | 16 | 17 | 10 | 11 | 10 | 10 | 11 | 12 | 14 | 17 | 21 |
| Depreciation | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 15 | 12 |
| Profit before tax | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax % | 23% | 16% | −56% | 25% | 25% | 25% | 16% | 17% | 18% | 16% | 22% | 22% |
| Net Profit | 5 | 7 | 21 | 21 | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| EPS in Rs | 3.19 | 4.22 | 4.82 | 4.62 | 5.43 | 5.85 | 5.9 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 30%
- 3 Years
- 26%
- TTM
- 32%
- 10 Years
- —
- 5 Years
- 57%
- 3 Years
- 130%
- TTM
- 26%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Entero Healthcare Solutions | ₹ 1,561.00 | ₹ 6,402 Cr. | 53.9x | 3.9x | 7% | — |
| Tata Consultancy Services | ₹ 2,528.00 | ₹ 9,14,653 Cr. | 15.7x | 7.7x | 48% | 18.2% |
| Infosys | ₹ 1,154.50 | ₹ 4,68,523 Cr. | 14.8x | 4.8x | 31.2% | 16.5% |
| HCL Technologies | ₹ 1,424.00 | ₹ 3,86,426 Cr. | 18.8x | 4.4x | — | 13% |
| Tech Mahindra | ₹ 1,789.40 | ₹ 1,75,385 Cr. | 27.9x | 5.2x | — | 8.7% |
| Billionbrains Garage Ventures | ₹ 181.65 | ₹ 1,13,960 Cr. | 61.3x | 13.3x | — | 46.5% |
Management
- Prabhat Agrawal
- Chief Executive Officer, Managing Director (Promoter)
- Sanu Vishal Kapoor
- Compliance Officer, Vice President - General Counsel, Company Secretary
- Prem Sethi
- Whole-Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.